Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06866691
PHASE4

Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide

Sponsor: Wake Forest University Health Sciences

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the incidence of early post-traumatic seizures. The study will also assess the benefit of lacosamide compared to levetiracetam in regards to agitation and behavioral adverse effects in patients with moderate to severe traumatic brain injury requiring seizure prophylaxis.

Official title: Comparison of Levetiracetam Versus Lacosamide for Seizure Prevention in Moderate to Severe Traumatic Brain Injured Patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

600

Start Date

2025-04-18

Completion Date

2027-04

Last Updated

2026-02-06

Healthy Volunteers

No

Interventions

DRUG

levetiracetam

levetiracetam 1000 mg intravenously or by mouth twice daily for a total of 7 days

DRUG

lacosamide

lacosamide 200 mg intravenously or by mouth twice daily for a total of 7 days

Locations (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States